Drug Delivery System
Online ISSN : 1881-2732
Print ISSN : 0913-5006
ISSN-L : 0913-5006
ナノテクノロジーとDDS
遺伝子を標的とする細胞内DDSとしてのオリゴヌクレオチド
佐々木 茂貴
著者情報
ジャーナル フリー

2002 年 17 巻 6 号 p. 478-485

詳細
抄録
Oligonucleotides attaching a reactive molecule may cause irreversible change to the target sequence at the reactive site. Inhibition of transcription, site-directed mutagenesis (or site-directed manipulation of genes) at the specific site has been proposed as a new tool of biotechnology with the use of a triplex-forming oligonucleotide. Thus, the oligonucleotides are regarded as a tool for intracellular DOS of useful reactive molecules. This review deals with development of a new alkylating group with high selectivity toward cytosine as well as new non-natural base analogs for the formation of stable non-natural triplexes.
著者関連情報
© 日本DDS学会
前の記事 次の記事
feedback
Top